Publication & Citation Trends
Publications
15 total
Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
Cited by 0
Semantic Scholar
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study. OA
Cited by 52
Semantic Scholar
Epidemiology and results of the first line therapy for HIV-related Hodgkin lymphoma OA
Cited by 3
Semantic Scholar
P1077: HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETROSPECTIVE MULTICENTER STUDY OA
Cited by 1
Semantic Scholar
Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study OA
Cited by 13
Semantic Scholar
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study OA
Cited by 49
Semantic Scholar
Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study OA
Cited by 2
Semantic Scholar
PS1465 SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH MYELOFIBROSIS (MF) AND ANEMIA (HB <10 G/DL): RESULTS AT WEEK (WK) 24 OF THE REALISE TRIAL OA
Cited by 3
Semantic Scholar
Research Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment
(6)
COVID-19 Clinical Research Studies
(3)
Chronic Myeloid Leukemia Treatments
(3)
Respiratory viral infections research
(3)
SARS-CoV-2 and COVID-19 Research
(2)
Affiliations
Petrozavodsk State University
Pirogov Russian National Research Medical University
Institute of Cardiology
City Clinical Hospital
Republican Clinical Hospital named after G.G. Kuvatova